Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Equity (2016 - 2025)

OptimizeRx (OPRX) has disclosed Return on Equity for 15 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 21.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, up 21.0% year-over-year, with the annual reading at 0.04% for FY2025, 21.0% up from the prior year.
  • Return on Equity hit 0.04% in Q4 2025 for OptimizeRx, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.04% in Q4 2025 to a low of 0.27% in Q3 2024.
  • Historically, Return on Equity has averaged 0.09% across 5 years, with a median of 0.09% in 2022.
  • Biggest five-year swings in Return on Equity: decreased -15bps in 2024 and later grew 27bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2021, then tumbled by -3155bps to 0.09% in 2022, then crashed by -132bps to 0.21% in 2023, then grew by 16bps to 0.17% in 2024, then surged by 124bps to 0.04% in 2025.
  • Business Quant data shows Return on Equity for OPRX at 0.04% in Q4 2025, 0.0% in Q3 2025, and 0.08% in Q2 2025.